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Introduction to analytical Chemistry
1. INTRODUCTION
                  Analytical chemistry is measurement science consisting of a set of powerful ideas
and  methods  that  are  useful  in  all  fields  of  science  and  method.  it  is  used  to  study the
chemical  composition,  structure  and  behavior  of  compounds.  The  purpose  of  chemical
analysis is together and interpret chemical information that will be the value of society in a
wide range of contexts. involves the application of a range of techniques and methodologies
to  obtain  and  assess  qualitative,  quantitative  and  structural  information  on  the  nature  of
components.[1,2]
       Qualitative analysis is the identification of elements and compounds present in a sample.
Quantitative analysis is the determination of the absolute or relative amounts of elements or
compounds present in a sample.
Structural  analysis is  the determination of  the special  arrangement of  atoms in an
element or molecule or the identification of characteristic groups or atoms.
A  typical  quantitative  analysis[2] involves  the  sequence  of  steps  shown  in  the
following flow diagram (figure-1)
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High Performance Liquid Chromatography[ 3,4,5,6,7]
High performance liquid chromatography is the fastest growing analytical technique
for the analysis of the drugs. Its simplicity,  high specificity and wide range of sensitivity
make it ideal for an analysis of many drugs in both dosage forms and biological fluids. HPLC
was developed in the late 1960s and 1970s. Today it is widely accepted separation technique
for both sample analysis and purification in variety of areas. 
Guide to Liquid Chromatography Mode Selection
Selection of chromatography mode is based upon the analyte polarity, solubility and
ionic nature. [7] A guide to liquid chromatography mode selection is represented in figure-2
Figure - 2 Guide to Liquid Chromatography Mode Selection Reverse Phase
HPLC
MW<2000
MW>2000
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Figure - 3 Block diagram showing the components of an HPLC instrument
F
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Reverse phase column packing
The liquid-liquid partition chromatography uses a stationary phase consisting of liquid
layer adsorbed to a surface of silica or alumina. In case of bonded phase or reverse phase
HPLC uses  a  stationary phase consisting of an organic moiety chemically bonded to the
surface of silica through the surface silanol groups. Since the organic moieties are generally
long-chain hydrocarbons, the mobile phases are generally polar. In this mode, the more polar
solutes are eluted first while the non-polar compounds are eluted later. The silanol group can
react with a chlorosilane group to form the popular (ODS & C18) octadecylsilane packing.
E.g. Octadecylsilane (ODS or C18).
CH3   CH3
Si     OH  + Cl  –   Si  – (CH2)17 – CH3               Si – O – Si – (CH2)17 – CH3 +HCl
CH3   CH3
  CH3
CH3
  For silica based bonded materials, the suitable working pH range is 2 - 8. At pH values of
less than 2, the Si-C bond is attached and at the higher pH values, hydrolysis of the siloxane
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takes  place  which  leads  to  degradation  or  destruction  of  the  packing.  In  most  of  the
applications of RP-HPLC, elution is carried out with highly polar solvents such as methanol,
acetonitrile or tetrahydrofuran in various concentrations. [8]
Reverse phase mobile phase
The primary constituent of RP-HPLC mobile phase is water. Water miscible solvents
such as methanol, ethanol, acetonitrile, dioxane, tetrahydrofuran and dimethyl formamide are
added to adjust the polarity of the mobile phase. Additionally acids, bases, buffers and/or
ionic  surfactants  are  added.  The  water  should  be  of  high  quality,  either  distilled  or
demineralised water.
The  most  widely  used  organic  modifiers  are  methanol,  acetonitrile  and
tetrahydrofuran. Methanol and acetonitrile have comparable polarities but acetonitrile is an
aprotic  solvent.  Ethanol,  1-propanol  and  2-propanol  are  also  useful  but  less  polar  than
methanol. Dioxane, tetrahydrofuran are aprotic solvents that are less polar than acetonitrile.
Reverse  phase  mobile  phases  are  generally  non-flammable  due  to  high  water  content.
Degassing is quite important with reverse phase mobile phases.[8] 
ANALYTICALMETHOD DEVELOPMENT [1,9]
Establishing  an  accurate  assay  procedure  for  each  ingredient  of  complex  dosage
formulation containing several  therapeutically and chemically compatible drugs with very
similar  chemical  nature  is  a  critical  process.  The  presence  of  excipients,  additives  and
decomposition products further complicates the analysis. Therefore analytical development is
done for few drugs where no compendial method is available.
Method development is done for:
 New drug products
 Already existing products
Methods are developed for new products when no official methods are available and
for already existing products to reduce the cost and time for better precision and ruggedness.
STEPS OF METHOD DEVELOPMENT1
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It starts with the documentation of the developed studies. All the data related to these
studies are established and recorded in laboratory notebook.
1. ANALYTICAL STANDARD CHARACTERIZATION
All the known information about the drug or analyte and its structure is collected such
as its  physical  and chemical  properties,  toxicity,  purity,  hygroscopic nature solubility and
stability.
a. The standard analyte is obtained. Necessary arrangement is made for proper storage in
refrigerator, desiccators and freezer.
b. When multiple components are to be analyzed in the sample matrix the number of
components  are  noted, data is assembled and the availability of standards for each
one is determined.
c. Special attention to be taken when sample is in less quality.
d. Only the methods which are compatible with sample stability are considered.
2. METHOD REQUIREMENTS
   The  objectives  of  method  are  defined.  The  required  detection  limits,  linearity,  range,
accuracy and precision are defined.
3. LITERATURE SEARCH AND RESEARCH METHODOLOGY
   Carry out the literature survey for all types of information to the analyte. Literature is done
for synthesis, physico-chemical properties, solubility and relevant analytical methods. Books,
periodicals,  chemical  manufacturers  and  regulatory  agency  compendia  such  as  USP/NF,
AOAC publications  are  reviewed  along with  chemical  abstract  service  (CAS)  automated
computerized literature searches.
a. If  any reported methods from the literature are adaptable to the current laboratory
setting and future needs are determined.
b. Using information in the literature and prints, methodology is adapted. The methods
are modified wherever necessary;  acquire additional existing methods for in house
analytes and samples.
c. If there are no prior methods for the analytes in the literature, the compounds that are
similar and chemical properties are investigated and are worked out.
4. INSTRUMENTAL SET UP AND INITIAL STUDIES
a. The  required  instrument  is  set  up.  Installation,  operational  and  performance  of
instrumentation using laboratory standard operating procedure are reviewed.
b. Always new consumables (solvents, filter and gases) are used.
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c. The  analyte  standard  in  a  suitable  injection/introduction  solution  and  in  known
concentration and solvents are prepared. It  is  important  to start  with an authentic,
known standard rather than with a complex sample matrix. If the sample is extremely
close to the standard (example: bulk drug) then it is possible to start work with the
actual sample.
d. Feasibility  of  method  with  regards  to  the  analytical  figures  of  merit  obtained  is
evaluated.
5. OPTIMIZATION
During optimization one parameter is changed at  a time and set  of conditions are
isolated rather than using a trial and error approach. Work has been done from an organized
methodological plan and every step is documented in case of dead ends.
6. DOCUMENTATION OF METHOD DEVELOPMENT WITH ACTUAL
SAMPLE
The sample solution should lead to absolute identification of the peak of interest apart from
all other matrix components.
7.  EVALUATION  OF  METHOD  DEVELOPMENT  WITH  ACTUAL
SAMPLE
        The sample solution should lead to absolute identification of the peak of interest apart
from all other matrix components.
8.  DETERMINATION  OF  PERCENT  RECOVERY  OF  ACTUAL
SAMPLE  AND  DEMONSTRATION  OF  QUANTITATIVE  SAMPLE
ANALYSIS.
 Percentage recovery was determined by adding authentic  standard analyte into a sample
matrix. Reproducibility of recovery from sample to sample and  has been determined. It is not
necessary to obtain 100% recovery as long as the results are reproducible and known with
high degree of certainty.
ANALYTICAL METHOD VALIDATION[10, 11, 12, 13, 35, 36]
Validation is a key process for effective Quality Assurance "Validation is establishing
documented evidence which provides a high degree of assurance that a specific process or
equipment  will  consistently  produce  a  product  or  result  meeting  its  predetermined
specifications and quality attributes.
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           The validation guidelines recommended from ICH (International Conference on
Harmonization) consists characteristics for consideration during the validation of analytical
procedures included as part of registration applications within EC, Japan and USA.
Type of analytical procedures to be validated
  Validation of analytical procedures is directed to the four most common types of analytical
procedures.
1. Identification test.
2. Quantitative test for impurities content.
3. Limit test for the control of impurities
4. Quantitative test of the active moiety in samples of drug substance on drug product on
other selected components in the drug product.
Assay procedures are intended to measure the analyte present in given sample, assay
represent a quantitative measurement of the major component(s) in the drug sample.
Objective of validation[14, 15]
              The primary objective of validation is to form a basis for written procedure for
production and process control which are designed to assure that the drug products have the
identity, strength, quality, purity, safety and efficacy.  Each step of the manufacturing process
must be controlled to maximize the probability that the finished products meet all quality and
design specification.
Benefits of Validation:
a. Produces quality products.
b. Helps in process improvement technology transfer, related product validation, failure
investigation, and increased employee awareness.
c. Cost reduction by increasing efficacy, few reject, longer equipment life, production of
cost effective products.
d. Helps in optimization of process or method.
e. Regulatory affairs department approved the products for export.
VALIDATION AS DEFINED BY DIFFERENT AGENCIES
1. USFDA: 
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According  to  this  "Validation  is  the  process  of  establishing documented  evidence
which provides a high degree of assurance that a specific process will consistently produce a
product meeting its predetermined specifications and quality attributes.
2. WHO:
Defines Validation as an action of providing any procedure, process, equipment,  material,
activity or system actually leads to the expected results.
3.   EUROPEAN COMMITTEE: 
Defines Validation as an action of providing in accordance with the principles of GMP that
any procedure, process, material, activity or system actually lead to expected results. This
process consists of establishment of the performance characteristics and the limitations of the
method.
Method performance parameters are determined using equipment that is:
1. Within specification.
2. Working correctly.
3. Adequately calibrated.
Method validation is required when:
1. A new method is developed.
2. Revision of established method.
3. When established methods are used in different laboratories and by different analysts.
4. Comparison of methods.
5. When quality control indicates method changes.
Typical analytical parameters used in assay validation include:
 Precision 
 Accuracy 
 Linearity 
 Range 
 Ruggedness 
 Robustness
 Limit  of  detection 
 Limit  of  quantitation 
 Selectivity 
 Specificity 
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PRECISION 
A) Precision
   The precision of an analytical procedure expresses the closeness of agreement between a
series of measurement obtained from multiple sampling of the same homogenous sample
under the prescribed conditions. Precision of an analytical procedure is usually expressed at
the variance, standard deviation or coefficient of variation of a series of measurements.  
 Validation of tests for assay and for quantitative determination of impurities includes
an investigation of precision.
Precisionisdeterminedbyusingthemethodtoassayasampleforasufficientnumberof  times  to
obtain statistically valid results (i.ebetween6-10).
Theprecisionisthen expressedastherelativestandarddeviation
                                                                            STDdevx100%
%RSD =
          Mean
Repeatability
It express the precision under the same operating conditions over a short interval of
time.  Repeatability is also termed as intra - assay precision. It should be assessed using a
minimum of nine determinations covering the specified range for the procedure (e.g. three
concentration/three  replicates  each) or  a  minimum of  determinations at  100% of the test
concentration.
Intermediate precision
The  extent  to  which  intermediate  precision  should  be  established  depends  on  the
circumstances  under  which  the  procedure  is  intended  to  be  used.   The  applicant  should
establish the effects of random events on the precision of the analytical procedure. Typical
variations to be studied include days, analysts, equipment, etc.
Reproducibility
  Reproducibility is assessed by means of an inter-laboratory trial.  Reproducibility should be
considered in case of the standardization of an analytical procedure, for instance inclusion of
procedures in Pharmacopoeias.  
ACCURACY
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 "Accuracy is a measure of the closeness of test results obtained by a method to the true
value." 
  Accuracy indicates the deviation between the mean value found and the true value. It  is
determined by applying the method to samples to which known amounts of analyte have been
added.  These  should be  analyzed against  standard  and blank  solutions  to  ensure  that  no
interference exists. The accuracy is then calculated from the test results as a percentage of the
analyte recovered by the assay.  Accuracy and precision are not  the same, as the diagram
below indicates. A method can have good precision and yet not be accurate.
                                                            Figure-4
Errors in measurement can be divided into two general categories: systematic errors
and random errors.
   Systematic errors result from sources that can be traced to the methodology, the instrument
or the operator and affect both the accuracy and the precision of the measurement.
            Random errors only affect the precision and are difficult to eliminate, because they
are the result of random fluctuations in the measured signal, due to noise and other factors.
            Whilst systematic errors are proportional to the sum of individual contributions,
random  errors  are  proportional  to  the  root  of  the  sum  of  the  squares  of  the  individual
contributions. Thus, the imprecision of the entire procedure is often dominated by the random
errors of the most imprecise step.
LINEARITY
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This is the method's ability to obtain results which are either directly, or after mathematical
transformation proportional to the concentration of the analyte within a given range. Linearity
is determined by calculating the regression line using a mathematical treatment of the results
(i.e. least mean squares) vs. analyte concentration.
 RANGE
    The range of the method is the interval between the upper and lower levels of an analyte
that have been determined with acceptable precision, accuracy and linearity. It is determined
on either a linear or nonlinear response curve (i.e. where more than one range is involved, as
shown below) and is normally expressed in the same units as the test results.
Figure- 5
RUGGEDNESS
Ruggedness is the degree of reproducibility of results obtained by the analysis of the
same sample under a variety of normal test conditions i.e. different analysts, laboratories,
instruments, reagents, assay temperatures, small variations in mobile phase, different  days
etc. (i.e. from laboratory to laboratory, from analyst to analyst.)
ROBUSTNESS
Robustness  is  depends  on  the  type  of  procedure  under  study.  It  should  show the
reliability of an analysis with respect to deliberate variations in method parameters. It is the
measure  of  capacity of  an assay to  remain by small  but  deliberate  variations  in  method
parameters  and  provide  an  indication  of  its  reliability  in  normal  usage  degradation  and
variation in chromatography column, mobile phases and inadequate method development are
common causes of lack of robustness.
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Examples of typical variations are
 Stability of analytical solutions
 Extraction time
 Influence of variation of pH in a mobile phase
 Influence of variation in mobile phase composition
 Different columns
 Temperatures
 Flow rate
LIMIT OF DETECTION
This is the lowest concentration in a sample that can be detected, but not necessarily
quantitated, under the stated experimental conditions. The limit of detection is important for
impurity tests and the assays of dosages containing low drug levels and placebos.
        The limit of detection is generally quoted as the concentration yielding a signal-to-noise
ratio of 2:1 and is confirmed by analyzing a number of samples near this value (6) using the
following equation. The signal-to-noise ratio (5) is determined by:
s = H/h
Where  H  =  height  of  the  peak  corresponding  to  the  component
             h = absolute value of the largest  noise fluctuation from the baseline of  the
chromatogram of a blank solution.
Since  the  limit  of  detection  is  dependent  on  the  signal-to-noise  ratio,  it can  be
improved  by  enhancing  the  analyte  signal  and  reducing  the  detector  noise. The signal
(i.e.  peak  height)  can  be  increased  by  selecting  the  optimum  monitoring  wavelength,
increasing the injection volume or mass (below signal or column saturation), increasing the
peak  sharpness  with  high  efficiency  columns  and  by  optimizing  the  mobile  phase.  For
absorbance detectors, longer path lengths in the flow cell enhance sensitivity though often to
the detriment of post column dispersion.
            Noise can be reduced by using high sensitivity detectors with low noise and drift
characteristics, slower detector response time, mobile phases with low absorbance and pumps
with low pulsation.
LIMIT OF QUANTITATION
This is the lowest concentration of analyte in a sample that can be determined with
acceptable precision and accuracy.
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It  is  quoted  as  the concentration yielding a  signal-to-noise  ratio  of  1  0:  1  and  is
confirmed by analyzing a number of samples near this value.
SELECTIVITY AND SPECIFICITY
Selectivity is the ability to measure accurately and specifically the analyte in the presence of
components that may be expected to be present in the sample matrix.
            Specificity for an assay ensures that the signal measured comes from the substance of
interest and that there is no interference from excipients and/or degradation products and/or
impurities.
Determination  of  this  can  be  carried  out  by  assessing  the  peak  identity  and
purity.
Diode array detectors can facilitate the development and validation of HPLC assays. Spectral
data obtained from diode array detectors, effectively supplement the retention time data for
peak  identification,  also spectral  manipulation often  provides  information  about  the  peak
purity. The table below lists several of the techniques available for assessing peak identity
and purity.
The purity index is a measure of the peak's relative purity, measured using a full comparison
of spectral data for the leading and training edge of the peak Figure 4. A value of 1.5 is
commonly accepted  to  indicate  a  pure  peak  but  >1.5  would indicate  the  presence  of  an
impurity, (9) as shown in Figure 6 & 7.
Figure- 6
Spectral comparison showing peak purity
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Comparison of reference versus sample apex spectra for peak identity
Figure-7
SYSTEM SUITABILITY TESTS (SST)
Once  a  method  or  system has  been  validated  the  task  becomes  one  of  routinely
checking the suitability of the system to perform within the validated limits.
            The simplest form of an HPLC system suitability test involves a comparison of the
chromatogram trace with a standard trace. This allows a comparison of the peak shape, peak
width, and baseline resolution.
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            Alternatively these parameters  can be calculated experimentally to  provide a
quantitative system suitability test report:
1. Number of theoretical plates (efficiency)
2. Capacity factor
3. Separation (relative retention)
4. Resolution
5. Tailing factor
6. Relative Standard Deviation (Precision)
These  are  measured  on  a  peak  or  peaks  of  known  retention  time  and  peak  width.
1. Plate number or number of theoretical plates (n)
This measures the sharpness of the peaks and therefore the efficiency of the column.
This can be calculated in various ways, for example the USP uses the peak width at the base
and the BP at half the Height.
An equation used to calculate ‘N’ is
N = 5.54[t/wh/2]2
Where
Wh/2 = peak width at 1/2 peak height Wb = peak width at base
t  =   retention time of peak
Figure- 8
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Therefore  the  higher  the  plate  number  the  more  efficient  the  column.
The plate number depends on column length - i.e. the longer the column the larger the plate
number. Therefore the column's efficiency can also be quoted as:
Either-  as  the  plate  height  (h), or the  height  equivalent  to  one  theoretical  plate
(HETP).
h= L/n
      Where L = length of column n
       Or - as plates/meter.
2. Capacity factor  (capacity  ratio)  k
This value gives an indication of how long each component is retained on the column
(i.e. how many times longer the component is retarded by the stationary phase than it spends
in the mobile phase).
Figure- 9
k'  is  used  in  preference  to  retention  time  because  it  is  less  sensitive  to  fluctuations  in
chromatographic conditions (i.e. flow rate) and therefore ensures greater reproducibility from
run to run. In practice the k value for the first peak of interest should be >l to assure that it is
separated from the solvent.
3. Separation Factor (relative retention)
This describes the relative position of two adjacent peaks. Ideally, it is calculated using the
capacity factor because the peaks' separation depends on the components' interaction with the
stationary phase.
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Therefore considering peaks A and B
Figure- 10
k  for  the  later  peak  is  always  placed  in  the  numerator  to  assure  a  value  >l.
If  the  capacity factor  is  used  then  the  separation  factor  should  be  consistent  for  a
given  column,  mobile  phase,  composition  and  specified  temperature,  regardless  of  the
instrument used.
4. Peak Resolution  R
  This is not only a measure of the separation between two peaks, but also the efficiency of
the column. It is expressed as the ratio of the distance between the two peak maxima. (At) to
the mean value of the peak width at base (Wb).
Figure- 11
5. Tailing Factor  T
This is a measure for the asymmetry of the peak.
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Figure- 12
6. Relative Standard  Deviation  or  precision
   For  an HPLC system this  would involve the reproducibility of  a  number  of  replicate
injections (i.e. 6) of an analytical solution.
The USP requires that unless otherwise specified by a method:
if a relative standard deviation of <2% is required then five replicate injections should be
used. if a relative standard deviation of >2% is required then six replicate injections should be
used Factors  which  could  affect  the  precision  of  an  HPLC  system are shown in table 1.
                                                Table No. 1
Precision Controlling  Factors
Retention  time Pump  flow and  composition  precision  Column  temperature Mobile
phase  composition
Peak  area Auto sampler:  inj  mode,  inj  volume 
Pump:  flow, pulsation 
Detector:  noise  and  drift,  response
 Data  system:  sampling  rate, integration  parameters
In most cases the system's Relative Standard Deviation is required; deciding which of the
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other  tests  are  required  is  not  straightforward.  To  assist  with  the  decision  it  has  been
suggested that those parameters which have an effect on the system precision should be used.
For  instance  the  resolution  of  two peaks  with  similar  retention  times  should  be  quoted,
because, if it is below a critical value, the precision will be affected.
            In addition "diode array" detectors allow for the determination of the relative purity
factor typically called: Peak Purity.
             The retention time precision is important, because not only is retention time the
primary method for peak identification, but also variations can indicate problems within the
LC system (i.e. with the piston seals, check valves etc). Use of a column oven can overcome
laboratory temperature variations, which is the most common cause of retention time drift.
    The most dominant factor controlling the repeatability of peak area is the auto sampler’s
precision, though the effect of noise and integration parameters will become more significant
with small peaks
METHODS USED FOR THE EXAMINATION OF PHARMACEUTICAL
MATERIAL MAY BE BROADLY CLASSIFIED AS:
CLASS A:  Tests designed to establish identity, whether of bulk drug substances or of a
particular ingredient in a finished dosage form.
CLASS B: Methods designed to detect and quantitate impurities in a bulk drug substance
or finished dosage form.
CLASS C:  Methods used to  determine quantitatively the concentration of  a  bulk drug
substance or of a major ingredient in a finished dosage form,
CLASS D:  Methods used to assess the characteristics of finished dosage forms such as
dissolution profile and content uniformity.
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2. PROFILE
2.1 DRUG PROFILE
i. ACETAMINOPHEN[16]
Category : Analgesic and antipyretic.
Nomenclature
IUPAC NAME : N-(4-Hydroxyphenyl) acetamide.
synonyms : Paracetamol
Chemical Structure of Acetaminophen
Fig-12Structure of Acetaminophen
Molecular Formula : C8H9NO2
Molecular mass : 151.2 g/mol
Solubility : Sparingly soluble in water, freely soluble in alcohol, 
very slightly soluble in ethylene chloride.
Melting point : 168 ℃ to 172 ℃
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ii. DEXTROMETHORPHAN HYDRO BROMIDE[17]
IUPAC name:Ent -3-Methoxy-17-methylmorphinan Hydrobromide monohydrate.
Chemical Structure of Dextromethorphan Hydro Bromide
Molecular Formula : C18H26BrNO, H2O
Molecular Weight : 370.3 g / mol
Appearance : Almost white, crystalline powder. 
Solubility : Sparingly soluble in water, freely soluble in 
alcohol.
Melting point : About 125 °C, with decomposition.  
Action and use : Cough suppressant.
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iii. PHENYLEPHRINE HCL[16]
Molecular Formula : C9H13NO2.    HCL
Chemical Structure of Phenylephrine HCl
.HCL
Molecular Weight : 203.67 g / mol
IUPAC name : 1R)-1-(3-hydroxyphenyl)-2-(methylamino) 
ethanol.  Hydrochloride
Appearance :  A white or almost white, crystalline powder
Solubility : Slightly soluble in water, sparingly soluble in  
methanol, slightly soluble in alcohol. It 
dissolves in dilute mineral acids and in dilute 
solutions of alkali hydroxides. 
Melting point : 174 °C.
Action and use : Sympathomimetic. 
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2.2IMPURITIES DRUG PROFILE
i. 4 – AMINOPHENOL[18]
Molecular Formula : C6H7NO.   
Chemical Structure of 4-Aminophenol 
Molecular Weight : 109.13 g / mol
IUPAC  name : 4-Amino  1- Hydroxy Benzen.
Appearance :  Crystalline powder, gradually become darker.
Solubility : Very soluble in water, soluble in alcohols
Melting point : 186 °C.
Action and use : Photographic developer .
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ii. 4 – CHLOROACETANILIDE[18]
Molecular Formula : C8H8ClNO.
Chemical Structure of 4-chloroacetanilide
Molecular Weight : 169.60 g / mol
IUPAC  name : N-(4-chloro phenyl) acetamide.
Appearance :  Orthorombic crystals.
Solubility : Practicallysoluble in water, freely soluble in 
                                                             alcohols, ether, carbon disulphide, slightly 
                                                             soluble in carbon tetra chloride.
Melting point :           178 – 179°C.
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3. LITERATURE REVIEW
D. B. Shepherd et al.,[19] have developed stability indicating HPLC method for the 
determination of acetaminophen and its related substance.
Column                   : Restek Ultra II® Pentafluorophenyl column 
   (150mm X 4.6mm, 5um)
Mobile phase A : 10mM ammonium acetate buffer/methanol/acetonitrile 
(90:5:5)
Mobile phase B : Methanol and Acetonitrile (50:50)
Wavelength detection : UV detector   at  272nm
Gradient program : 100% Mobile Phase A for 7 minutes
  60% Mobile Phase B at 12minutes
The method was linear, accurate and precised for 4-aminophenol and other unknown 
impurities between 0.25ug/mL to 5ug/mL(0.05% - 1.0% Acetaminophen). 
Badea1*et al.,[20] were developed and validated Reverse Phase High Performance  
liquid Chromatography (RP-HPLC) method for the estimation of acetaminophen and it’s
main impurities 4-nitrophenol, 4-chloroacetanilide as well as 4-aminophenol and it’s
degradation products p-benzoquinone and hydroquinone.
Column : Hypersil Duet C18/SCX column
Mobile phase : Phosphate buffer (pH 5& 4.88) and methanol
Gradient program : Using gradient elution
The limits of detection and quantification was established to be lower than 0.1 mg/mL and 
0.5 mg/mL, respectively. The method was successfully applied for the analysis of 
Commercial acetaminophen preparations.
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Eglal A. Abdelaleem et al.,[21]have developed and validated  a simple, sensitive and   
stability indicating RP-HPLC method for the determination of  related substance  of 
Paracetamol and methocarbamol (4-Aminophenol  and guaifenesine) in their bulk powders 
and laboratory prepared mixtures.
Column :  ODS column 
Mobile phase : 0.05 M KH2PO4  buffer : Acetonitrile 
  (72.5:27.5, v/v, pH = 6)
Flow rate : 1.0mL/min   
Wavelength detection : U V detection at 225nm.
The developed method was validated as per ICH guidelines and the calibration plots 
Were linear over the concentration ranges of 3–20, 4–25, 0.6–8 and 0.6–8 µg mL−1 
For Paracetmol, Methocarbamol, 4-Aminophenol and Guafenesine, respectively.
Gnana Raj M et al.,[22] have  reported a validated  stability indicating RP-HPLC method 
for the  simultaneous estimation of related compounds of ibufrophen and paracetamol  in the 
tablet dosage form.
Column :   RP 18 Embedded polar phase column
 Mobile phase :  Acetonitrile and 0.1 %of orthophosphoric acid (55:45)
Wavelength detection : U V detection at 230nm.
The developed method was validated as per  USP and ICH guidelines.
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T.A. Phazna Devi1 etal.,[23]have  developed High  Performance Liquid 
Chromatography (RP-HPLC) for the determination of paracetamol.
Column                   : C18 column [4.6x250mm, particle size 5µm].
Buffer                            : Ortho phosphoric acid buffer with pH of 3.5. 
Mobile phase                : Acetonitrile (ACN)  and  water  (25:75 v/v).
Flow rate                       : 1mL/min
Wavelength detection   : UV detector   at  207nm
The statistical validation parameters such as linearity, accuracy, precision, interday and    
intraday variation were checked. The limit of detection and limit of quantification of 
paracetamol  concentrations were found to be 120ng/mL and 360ng/mL. Recovery and 
assay studies of paracetamol were within 99 to 102% and it was shown that the proposed 
method could be adoptable for quality control analysis of paracetamol.
Sadana Gangishettyet al.,[24]were  described a simple, rapid  and reproducible reverse 
Phasehigh performance liquid chromatography (RP-HPLC) method for the simultaneous 
estimation of clarithromycin (CLA) and paracetamol (PCM).
Column :  C18 column (Kromasil ODS, 5µm, 250 × 4.6mm) 
Mobile phase :  Phosphate buffer (0.05M) along with 1-octane sulphonic 
  acid sodium   salt  monohydrate (0.005M) adjusted to
  pH 3.2: acetonitrile (50:50).
Flow rate : 1mL/min
Wavelength detection : UV detector at 205nm
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The developed method was validated according to ICH guidelines Q2 (R1) and found to be 
linear within the range of 75–175µg/mL for both drug.
Arunadevi S. Birajdar* et al.,[25]   have  developed  high-performance liquid 
Chromatographic  method for the simultaneous estimation of paracetamol and tramadol in 
combined solid dosage form.
Column :  C18 reverse-phase column
  (250 X 4.6 mm I.D., particle size 5µm). 
Buffer :  Triethylamine buffer (pH 7.3)
Mobile phase :  Acetonitrile- 0.26 % Triethylamine buffer (pH 7.3) in ratio of 
   (45:55 % v/v)
Flow rate :  1mL/min
Wavelength detection : UV detector at 264nm
The method was linear over the concentration range of 1.0-12.0 µg/mL for paracetmol and 
0.1-1.2 µg/mL for tramadol. Domperidone was used as an internal standard (IS).                 
The analytical recovery obtained was 99.88%. The validation of method carried out as per 
ICH guidelines.
Swapnalee et al.,[26]have developed  simple, selective, rapid, précised  and economical 
RP-HPLC method  for the determination of Acetaminophen Caffeine, Phenylephrine 
Hydrochloride and Dextromethorphan Hydrobromide in the tablet formulation.
Column : Inertsil C8 (4.6 mm x 15 cm, 5 µm)
Buffer : Sodium salt of heptane sulphonic acid buffer solution
Mobile phase : Sodium salt of heptane sulphonic acid buffer solution and 
 Acetonitrile
Flow rate : 1mL/min
Wavelength detection : UV detector at 214nm
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Fuad Al-Rimawi [27] had  developed  simple, précised and accurate validated 
HPLC method for the analysis of pseudophedrine hydrochloride, dextromethorphan 
hydrobromide, chlorpheniramine maleate, and paracetamol in tablet formulations.
Column : Silica column (5 µm, 125 × 4.6 mm inner diameter) 
Buffer : Ammonium dihydrogen phosphate buffer
Mobile phase : Methanol: Ammonium dihydrogen phosphate buffer
  (90:10, v/v)
Flow rate : 1mL/min
Wavelength detection : UV detector at 220nm
This new method was validated in accordance with USP requirements for assay 
accuracy, precision, selectivity, linearity and range, robustness and ruggedness.
I.M. Palabıyık et al.,[28]have  developed and validated HPLC method for the 
simultaneous determination of phenylephrine hydrochloride, paracetamol, 
chlorpheniramine maleate and dextromethorphan hydrobromide in pharmaceutical 
preparations.
 Column : C18 column
 Mobile phase : Acetonitrile–Sodium perchlorate (0.01M, pH 3)
 Flow rate : 1.4mL/min   
 Wavelength detection : UV detector at 204nm
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Thummala V. et.al.,[29]  have developed sensitive, stability indicating gradient RP-HPLC
method for the simultaneous estimation of impurities of Guaifenesin and Dextromethorphan 
in pharmaceutical formulations.
Column                            : Sunfire   C18, 250cm×4.6mm, 5µm column
Mobile phase                   : Gradient mixture of solvents A and B
Flow rate                         : 0.8mL/min   
Wavelength detection     : UV detector at  224nm
The developed method was validated according to ICH guidelines with respect to specificity, 
Linearity, limits of detection and quantification, accuracy, precision and robustness. 
Regression analysis showed an r2 value (correlation coefficient) greater than 0.999 for 
Guaifenesin, Dextromethorphan and the impurities.
A. Marın et al.,[30]have developed and validated a RP-HPLC method for the simultaneous
estimation of acetaminophen, phenylephrine and chlorphenaramine in pharmaceutical dosage 
form.
Mobile phase :  Mobile phase A : Mobile phase B (92:8)
Mobile phase A : Phosphate buffer 40mM at pH 6.0 
Mobile phase B :  Acetonitrile
Wavelength detection : UV detector 215nm for phenylephrine and chlopheniramine
  acetaminophen at 280nm
Gradient program : 75% Mobile Phase 25% Mobile phase B   for 8 minutes
   30% Mobile phase A 70%  Mobile Phase B at 5minute
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Rouhollah Heydariab*[31] was reported validated HPLC method  for the simultaneous
estimation of acetaminophen, phenylephrine, dextromethorphan and chlorpheniramine in 
pharmaceutical formulation
Column : 25 cm underivatized silica column
Mobile phase : Methanol: water (containing 6.0 g of ammonium   
  acetate and 10 ml of triethylamine per liter, pH adjusted       
  to 5.0 with orthophosphoric acid), 95:5%(v/v)
Wavelength detection : UV-vis detector at 254 nm for acetaminophen
  at 220 nm for phenylephrine, and at 227 nm for   
  dextromethorphan and chlorpheniramine.              
The method  showed linearity for the acetaminophen, phenylephrine, dextromethorphan, and
chlorpheniramine in the 162.5–650, 2.5–10, 7.5–30, and 1–4 µg/ml ranges, respectively. 
The intraday and interday RSDs ranged from 0.92 to 1.52%, 1.00 to 1.76%, 1.21 to 1.74% 
and 1.26 to 1.80% for the acetaminophen, phenylephrine, dextromethorphan, and 
chlorpheniramine, respectively.              
Marın et al.,[32]have developed  HPLC method for the simultaneous determination of 
acetaminophen, phenylephrine and chlorpheniramine in capsules as pharmaceutical 
formulation after their dissolution test.
 Column :  HS PEG column (polyethylene glycol), 5 µm, 
Mobile phase : 20 mM phosphate buffer at pH 7.0/acetonitrile 80:20 (v/v).
Flow rate : 1mL/min   
 Wavelength detection : UV detection  at 210 nm for phenylephrine and 
chlorpheniramine and  at 305 nm for acetaminophen.
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 
                                                                                                                     Literature Review
The validation parameters of both techniques were adequate for the intended purpose.
JOSHI et al.,[33]have developed and  validated isocratic RP-HPLC method for the 
simultaneous  estimation of dextromethorphan hydrobromide and levocetirizine
dihydrochloride in a cough syrup. The method was validated as per ICH guidelines.
Column : Phenomenex (USA) C18 analytical column, 250x4.0 mm
Mobile phase : potassium dihydrogen phosphate buffer (pH 2.5) – acetonitrile
  and tetrahydrofuran (70:25:5, v/v/v).
Flow rate : 1.2mL/min   
Wavelength detection : U V detection at 232nm 
Brahmbhatt* et al.,[34]have reported simple, accurate and precised RP-HPLC method 
 for Tramadolhydrochloride (THC) and Paracetamol (PCM).
Column : C18 ODS column (150 × 4.6 mm)
 Mobile phase : Water : Methanol (70:30 v/v) at pH 3.4 adjusted by 5% 
  o-phosphoric acid
Flow rate : 1.0mL/min   
Wavelength detection : U V detection at 228nm.
Linearity was observed over the concentration range of 195-455 µg/ml and 22.5-52.5 µg/ml
for PCM and THC respectively. The LOD was found to be 6.999 and 0.80 for PCM  and THC
respectively.  LOQ was found to be 2.10 for PCM and 2.42 for THC. Moreover, the % RSD
for repeatability, inter and intraday precision was found to be less than 2%, which reveals that
the method is precise. The % recovery was found to be 99.83%- 100.30%. For PCM and
98.52- 101.64% for THC.
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4. AIM AND PLAN OF WORK
Aim and scope 
Acetaminophen, Dextromethorphan HBr and Phenylephrine HCl are official in U.S.P.  From
the literature survey, it was found that there were only few RP-HPLC methods reported for
the estimation of related substances of Acetaminophen in tablet formulation and  no analyt-
ical method was reported for the estimation of related substances of  acetaminophen  in cap-
sule formulation.
Hence, the aim of present work is to develop RP-HPLC method for estimation of related sub-
stances of Acetaminophen in acetaminophen, phenylephrine Hcl and   dextromethorphan HBr
soft gelatin capsules and to validate the developed RP-HPLC method by validation paramet-
ers as per ICH guidelines.
Plan of present work 
 Method development (By reverse phase HPLC).
 Validation of the developed method (By using following parameters).
a. System suitability studies
b. Limit of Detection
c. Limit of Quantification
d. Linearity and Range
e. Accuracy
f. Precision
g. Specificity
h. Robustness
i. Ruggedness 
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5. MATERIALS AND INSTRUMENT USED
a) Active Ingredients used:
S.No.  Name Specification 
1. Acetaminophen As Referance standard
2. 4-Aminophenol As Referance standard
3. 4-Chloroacetanilide As Referance standard
4. Dextromethorphan HBr As Referance standard
5. Phenylephrine Hcl As Referance standard
b) Apparatus / Instruments used:
S.No.         NAME    MODEL MANFACTURER/SUPPLIER
1. Weighing balance AUM220D        Schimadzu
2. Sonicator sonorex         Sonorex dg 10p
3. pH Meter 9087         ELICO pH METER
4. HPLC-UV,PDA LC-2010          Schimadzu
5. Colum Zodiac C18          Zodiac
     C) Chemical used:
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S.No. NAME GRADE MANFACTURER/SUPPLIER 
1.
Pottasium di hydrogen
orthophosphate HPLC Rankem Chemicals
2.
1-pentane sulponic acid
sodium salt HPLC Rankem Chemicals
3. Acetonitrile HPLC Afladam Chemicals
4. Methonol HPLC Rankem Chemicals
5. Phosphoric acid HPLC Merck Chemicals
6. Tri Ethylamine HPLC Rankem Chemicals
7. Milli-Q Wter HPLC In House production
Method Development
6. RP-HPLC METHOD DEVELOPMENT
 The  method  development  stage,  decision  regarding  choice  of  column,  mobile  phase,
detectors and method of quantitation must be addressed. In this way, development considers all
the parameters pertaining to any methods [15].
(1)Selection of stationary phase
Proper selection of  the stationary phase depends up on the nature  of  the sample and
chemical profile.  The drug selected for the present study was polar compound and could be
separated  either  by  normal  phase  chromatography  or  reverse  phase  chromatography.  From
literature  survey,  it  was  found that  different  C18columns could be appropriately used for  the
separation of related substances for Acetaminophen.
(2)Selection of wavelength 
The sensitivity of the HPLC method depends upon the selection of detection wavelength.
An ideal wavelength is one that gives good response for related substances and the drugs to be
detected.  The  wavelength  for  measurement  was  selected  as  245  nm  from  the  absorption
spectrum.
(3)Selection of mobile phase 
          The mobile phase was selected and chromatograms were recorded, trails were done on
different mobile phases. 
TRIALS
 Trial-1
Buffer preparation: 
6.8 g of  Potassium dihydrogen orthophosphate was dissolved in  1000 mL of  milli-Q
water and pH was adjusted to 3.0 with orthophosphoric acid. Then it was filtered through 0.45 µ
nylon membrane filter and degassed. 
Mobile phase A: Buffer (70%)
Mobile phase B: Methanol(30%)
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Chromatographic conditions          
Column              : Zodiac C-18, (250 × 4.6 mm, 5 µ)
Detector wavelength              : 245 nm
Column temperature              : 30 oC 
Injection Volume              : 10 µL
Flow rate                         : 1.0 mL/min 
Runtime              : 55 min 
Observation:
Resolution of peaks  were not satisfactory for 4-Aminophenol, Phenylephrine HCl and
Acetaminophen and Dextromethorphan HBr.
                                                       Figure-13
Trial 2:
Buffer Preparation: 
2.0 g of Sodium di hydrogen orthophosphate was dissolved in 1000 mL of milli-Q water
and pH was adjusted to 3.0 with orthophosphoric acid. Then it was filtered through 0.45 µ nylon
membrane filter and degassed. 
Mobile phase A: Buffer (70%)
Mobile phase B: Acetonitrile(30%)
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Chromatographic Condition:
Column & ID NO : Zodiac C-18, (250 × 4.6 mm, 5 µ)
Column temperature : 30oC 
Inj. Volume : 10 µL
Flow rate : 1.0ml/min
λmax                                              : 245 nm
                                               Figure-14
Observation:
Resolution of peaks  were  not satisfactory for 4-Aminophenol, Phenylephrine HCl and
Acetaminophen and Dextromethorphan HBr
Trial 3: (Optimized Method)
Buffer preparation – 1
1.92g of 1-Pentane sulphonic acid sodium salt was dissolved in 1000ml distilled water followed
by the addition of 0.1ml Triethylamine and pH was adjusted to 6.0 with Orthophosphoric acid.
Buffer preparation - 2:
6.8g of potassium Dihydrogen ortho phosphate   was dissolvedin1000ml distilled water and  pH 
was adjusted to 3.0 with orthophosphoric acid.
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Mobile phase A: Buffer-1: Methanol (85:15)
Mobile phase B: Buffer-2: Acetonitrile (70:30)
Chromatographic conditions          
Column            : Zodiac C-18, (250 × 4.6 mm, 5 µ)
Detector wavelength            : 245 nm
Column temperature            : 30 oC 
Injection Volume            : 20 µL
Flow rate                       : 1.0 mL/min 
Runtime            : 55 min 
Diluent                                            : Mobile phase-A
Gradient Program:
                                                                Table No: 2
Time (mins) Mobile phase-A (%) Mobile phase-B (%)
0.01 100 0
15.0 100 0
30.0 0 100
45.0 0 100
50.0 100 0
55.0 100 0
                                                                             Figure-15
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Observation:
Resolution was  satisfactory for 4-Aminophenol, Phenylephrine HCl and Acetaminophen
and Dextromethorphan HBr.
Sample preparation
Preparation of sample solution:    
8000mg of medicament was accurately weighed (equivalent to 2000mg of Acetaminophen)  and
transfered into a 100 ml volumetric flask.70mL of diluent  was  added   and sonicated  for
30minutes. Finally volume was made up with diluents and Filtered the solution through whatman
filter no:42.
Preparation of Diluted Standard Solutions: 
Acetaminophen: 
50mg of Acetaminophen working standard was accurately weighed and transfered into a 50 ml
Volumetric flask.30ml of diluent was added and sonicated and volume was made up with diluent.
5mlof stock solution was pipetted out  into a 50 ml volumetric flask and finally volume was
made up with diluent (Solution 1). 
4-Chloroacetanilide: 
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20mg of 4-Chloroacetanilide working standard was  accurately  weighed  and transferred in to a
50 ml Volumetric flask.  30ml  of  diluent  was added  and  sonicated. Then volume was made up
with diluent.5ml of stock solution was pipetted out into a 50 ml volumetric flask and  volume
was  made   up   with  diluent.  5ml  of  resulting   solution  was  pipetted  out  into  a  100ml  of
volumetric flask and finally volume was made up with diluent (Solution 2).
4-aminophenol: 
50mg of 4-Aminophenol working standard  was accurately weighed and transfered into a 50 ml
Volumetric flask .30ml of diluent was added and  sonicated . Then volume was made up with
diluent.10ml of stock solution  was  pipetted  out  into a 50 ml volumetric flask and finally
volume was  made up  with diluent (Solution 3).
Resolution solution: (Diluted standard)
 20mg  of  Phenylephrine  HCl  WS/RS  and  10mg  of  Dextromethorphan  HBr  WS/RS  were
accurately weighed and transfered into a  50ml volumetric  flask. 10ml of Solution 1,  5ml of
Solution 2  and 5ml of  Solution 3, were   added into a 50ml volumetric flask and finally volume
was  made up  with diluent.
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7. METHOD VALIDATION
VALIDATION
According to ICH guidelines method validation can be defined as “Establishing 
documented evidence, which provides a high degree of assurance that a specific activity will 
consistently produce a desired result or product meeting its predetermined specifications and 
quality characteristics” [18]. Such validated analytical method for qualitative and quantitative 
testing of the drug molecule assume greater importance when they are employed to generate 
quality and safety compliance data during development, pre-formulation studies and post 
approval of drug products. 
The ICH of Technical Requirements for the Registration of Pharmaceutical for human
use has developed a consensus text on the validation of analytical procedures. The document 
includes definitions for eight validation characteristics
Parameters Used for Assay Validation
The validation of the assay procedure was carried out using the following parameters.
1) Parameters:
1.1 System suitability
1.2 Specificity
1.3Limit of Detection
1.4Limit of Quantification
1.5Linearity and Range
1.6Accuracy
1.7Precision
1.8Robustness
Reagents: 
Buffer preparation – 1
1.92g of 1-Pentane sulphonic acid sodium salt  was dissolved in 1000ml  distilled Water  
followed by  the  addition of 0.1ml Triethylamine and  pH was  adjusted to  6.0 with 
Orthophosphoric acid.
Buffer preparation - 2:
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6.8g of potassium Dihydrogen orthophosphate  was  dissolved in1000ml distilled water and  
pH was  adjusted to 3.0 with orthophosphoric acid.
Mobile Phase:
Mobile Phase – A:
850ml of Buffer-1 and 150ml of Methanol were mixed.  Then solution was filtered through 
0.45µm nylon membrane filter and it was degassed.
Mobile Phase – B:
700ml of Buffer-2 and 300ml of Acetonitrile  were mixed. Then  solution was  filtered 
through 0.45µm nylon membrane filter and  it was degassed.
Diluent:   Mobile phase – A
Gradient Program:
                                       Table No:2
Time (mins) Mobile phase-A (%) Mobile phase-B (%)
0.01 100 0
15.0 100 0
30.0 0 100
45.0 0 100
50.0 100 0
55.0 100 0
7.1 PREPARATION OF STANDARD AND SAMPLE SOLUTION:
STANDARD PREPARATION:
Acetaminophen:  
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 50mg of Acetaminophen  working standard  was  accurately  weighed  and transfered into a 
50 ml Volumetric flask,  30ml of diluent  was added  and  sonicated. Then volume  was  made
up with diluent. 5ml of stock solution  was  pipetted out  into a 50 ml volumetric flask and 
finally volume was made up with diluent (Solution 1). 
4-Chloroacetanilide: 
20mg of 4-Chloroacetanilide  working standard  was  accurately  weighed  and  transferred in
to a 50 ml Volumetric flask. 30ml  of  diluent  was added  and  sonicated. Then volume  was 
made up  with diluent. 5ml of stock solution was  pipetted out into a 50 ml volumetric flask 
and  volume was  made  up  with  diluent.  5ml of resulting  solution was pipetted out into a 
100ml of volumetric flask and finally volume was made up with diluent (Solution 2).
4-aminophenol: 
50mg of 4-Aminophenol  working standard  was  accurately weighed and transfered  in to a 
50 ml Volumetric flask. 30ml of diluent was added and  sonicated. Then  volume was made 
up  with diluent. 10ml of stock  solution  was  pipetted  out  into a 50 ml volumetric flask and 
finally volume was  made up  with diluent (Solution 3).
Resolution solution: (Diluted standard)
20mg of  Phenylephrine HCl WS/RS and 10mg of  Dextromethorphan HBr WS/RS were 
accurately  weighed and  transfered  into a 50ml volumetric flask. 10ml of Solution 1, 5ml of 
Solution 2, and 5ml of Solution 3 were added  into  a 50ml volumetric flask  and  finally  
volume  was made up  with diluent.
Sample Preparation:
8000mg of medicament  was accurately  weighed (equivalent to 2000mg of Acetaminophen)  
and transfered  into  a 100 ml volumetric flask . 70mL of diluent  was  added   and   sonicated
for  30minutes.  Finally  volume  was  made up  with  diluent and Filtered the solution 
through  whatman filter no: 42.
Spiked Sample Preparation:
8000mg of medicament was accurately weighed (equivalent to 2000mg of Acetaminophen) 
and  transfered  into a 100 ml volumetric flask. 10ml of Solution-2, 10ml of Solution-3 and 
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70mL of diluent were added and sonicated for 30minutes. Finally volume was made up  with 
diluent and Filtered the solution through  whatman filter no: 42.
7.2 CHROMATOGRAPHIC PARAMETERS:
  The liquid chromatographic system was set as follows:
                                            Table No: 3
Instrument HPLC with UV/PDA detector
Column C18 – 250 mm x 4.6 mm, 5m (zodiac or 
equivalent)
Flow rate 1.0 ml/min.
Oven temperature 30.0°C
Sample temperature Ambient
Diluent Mobile phase
Wavelength 245 nm 
Injection volume 20 µl 
Calculation:
Calculation of impurities:
   (1)   4- Aminophenol = 
AKIT1    x    WS1 x 10 x 5  x   100   x    P1    x  Avg.net weight in mg  x 100
ADS1           50         50       50         WT       100                  LCA
(2)   4- Chloroacetanilide = 
AKIT2  x  WS2  x   5     x   5   x    5   x 100   x  P2    x  Avg.net weight in mg  x 100
    ADS2        50        50      100      50     WT     100                LCA
(3) Total Unknown impurities =
ATIT1    x    WS3   x   5   x  10  x  100   x   P3    x  Avg.net weight in mg  x 100
       ADS             50         50      50        WT        100              LCA
AKIT1= Area of 4-Aminophenol impurity obtained from test preparation. 
AKIT2= Area of 4-Chloroacetanilide impurity obtained from test preparation. 
ATIT1 = Sum of all peak area in test solution – [Test solution Known impurity peak area   + 
Acetaminophen peak area]  
ADS = Area of Acetaminophen peak obtained from Resolution solution.
ADS1 = Area of 4- Aminophenol peak obtained from Resolution solution.
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ADS2 = Area of 4- Chloroacetanilide peak obtained from Resolution solution. 
WS1 = Weight of 4- Aminophenol working standard taken in mg. 
WS2 = Weight of 4-Chloroacetanilide working standard taken in mg. 
WS3 = Weight of Acetaminophen working standard taken in mg. 
WT  = Weight of test sample taken in mg for test preparation.
P1   = Purity of 4- Aminophenol working standard as such basis in %.  
P2   = Purity of 4-Chloroacetanilide working standard as such basis in %.         
P3 = Purity of Acetaminophen working standard as such basis in %.        
LCA    = Label claim of Acetaminophen.
Acceptance Criteria:
1. 4-Chloroacetanilide: NMT 0.001
2. 4-aminophenol: NMT 0.1%
3. Total Unknown impurities: NMT 0.1%
SYSTEM SUITABILITY
System suitability parameters and recommendations were shown in the table no.4
Table no. 4 System suitability parameters and recommendations
S.N
o
Parameters Recommendations
1
Theoretical plates 
(N)
>2000
2 Tailing factor (T) ≤ 2
3 Resolution (Rs)
> 2 between peak of interest and the closest 
eluting potential interference
4 Repeatability RSD ≤ 2% for N ≥5 is desirable
5 Capacity factor (k1) > 2.0
6 Relative retention Not essential as long as the resolution is stated
Procedure:
A standard solution (resolution solution) was injected .Six times into HPLC system and 
system suitability parameters were evaluated. Chromatograms were shown in the figure-
16 and data was shown in the table no.5, 6and 7.
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Figure -16 Chromatogram for system suitability
      Table No: 5   Data for system suitability (4-Aminophenol)
No of Injection RT Theoreticalplate Tailing factor Peak response
01 5.11 4671 1.3 692972
02 5.11 4517 1.3 692924
03 5.11 4503 1.3 690825
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04 5.11 4301 1.3 698031
05 5.11 4372 1.3 696874
06 5.12 4306 1.3 694740
Mean 5.11 4445 1.3 694394
SD 0.004 144.9 0.0 2698.8
%RSD 0.1 3.3 0.0 0.4
       Table No: 6  Data for system suitability   (Acetaminophen)
No of Injection RT Theoreticalplate Tailing factor Peak response
01 9.98 6752 1.1 1747425
02 9.99 6767 1.1 1757528
03 10.00 6671 1.2 1747334
04 10.01 6551 1.2 1746367
05 10.02 6430 1.2 1741372
06 10.02 6331 1.2 1754869
Mean 10.00 6584 1.2 1749149
SD 0.0 177.8 0.1 5956.7
%RSD 0.2 2.7 4.4 0.3
      Table No: 7  Data for system suitability (4-Chloroacetanilide)
No of Injection RT Theoreticalplate Tailing factor Peak response
01 41.04 83527 1.2 24726
02 41.05 82925 1.2 24627
03 41.05 81857 1.2 24491
04 41.06 81225 1.2 24435
05 41.06 80478 1.2 24172
06 41.05 79680 1.2 24230
Mean 41.05 81615 1.2 24447
SD 0.0 1457.4 0.0 216.8
%RSD 0.0 1.8 0.0 0.9
SPECIFICITY 
Blank, standard, placebo, all known related compounds, spiked sample, sample 
solutions were prepared and injected into the chromatographic system for identification and 
interference with the Acetaminophen, Phenylephrine HCl and Dextromethorphan HBr peaks. 
a. Placebo Interference:
A study to establish the interference of placebo was conducted. Sample preparation of 
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placebo was done as that of test sample preparation of assay method. Chromatogram of 
placebo did not show any additional peaks. This indicated that the excipients used in the 
formulation did not interfere in the RS of Acetaminophen, Phenylephrine HCl and 
Dextromethorphan HBr Capsules. Resulted chromatograms were shown in the figure-
17,19,20 and data was shown in the table no 8 and 9.
  Figure-17 Chromatogram for placebo
BLANK INTERFERENCE:
A study to establish the interference of blank was conducted. Diluent was injected as per the 
test method. Chromatogram was appended in figure no.18   and data was shown in table no.  
8 and 9.  
                       Figure-18 Chromatogram of blank
              Figure-19 Chromatogram of standard
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Figure-20 Chromatogram of Sample
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Table No: 8    Data for placebo and blank interference
RT Peak response Peak Purity index
Blank NA NA NA
Placebo NA NA NA
Working standard
4-Aminophenol
Acetaminophen
4-Chloroacetanilide
6.70
9.53
40.67
682115
1631649
29851
1.000
1.000
0.999
Sample with spike
4-Aminophenol
Acetaminophen
4-Chloroacetanilide
6.50
8.77
39.69
693280
201805492
30457
0.999
0.999
1.000
Acceptance criteria: 
No interference was found at the retention times of Acminophen, 4-Aminophenol and 
4-Chloroacetanilide.
Table No: 9 Interference of blank, placebo and impurity
Name Interference Retention time( minutes)
Blank Nil Nil
Placebo Nil Nil
Precision: 
Method Precision:
Six spiked sample preparations were prepared individually using single batch of 
Acetaminophen, Phenylephrine HCl and Dextromethorphan HBr Capsules  as per test 
method and injected each solution. Resulted chromatogram was shown in the figure-21. and
data was shown in the Table no.10 & 11.
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Figure No: 21 Chromatograms for sample
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Table No: 10 Data for repeatability
No. of
Sample 
4-aminophenol 4-Chloroacetanilide Total Impurity
%
01 103.2 101.7 0.03
02 101.9 105.8 0.04
03 102.5 105.9 0.03
04 104.1 101.3 0.03
05 103.9 104.3 0.04
06 102.4 101.3 0.04
Mean 103.0 103.4 0.04
SD 0.8 2.2 0.005
% RSD 0.8 2.1 12.5
Confidence 0.42 0.56 0.00
Table No: 11 Results of method precision
System Suitability Results Acceptanc
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Parameters e criteria
4-
Aminopheno
l
Acetaminophe
n
4-
Chloroacetanili
de
Tailing factor for 
Acetaminophen, 4-
Aminophenol and 4-
Chloroacetanilide 
peaks from first 
standard injection.
1.3 1.1 1.2 NMT 2.0
Theoretical plate count
for Acetaminophen, 4-
Aminophenol and 4-
Chloroacetanilide 
peaks from first 
standard injection.
4671 6752 83527 NLT 2000
 The %RSD of RT for 
six replicate injection 
of standard solution 
(for 4-Aminophenol, 
Acetaminophen and 4-
Chloroacetanilide)
0.1 0.2 0.0 NMT 1.0
 The %RSD of Peak 
response from six 
replicate injection of 
standard solution (for 
4-Aminophenol, 
Acetaminophen and 4-
Chloroacetanilide)
0.4 0.3 0.9 NMT 2.0
 Resolution between 4-
Aminophenol and 
Acetaminophen 
injection from first 
standard injection.
12.4 N/A NLT 2.0
% recovery of known 
impurities in six spiked
samples
103.0 N/A 103.4 90.0-110.0
 % RSD of known 
impurities in six spiked
samples.
0.8 N/A 2.1 NMT 10.0
Ruggedness & Intermediate Precision:
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 56
Method Validation for Related Substances
Intermediate precision experiment was repeated by a second analyst a different HPLC system
and a separate HPLC column on a different day. The second analyst prepared all reagents, 
sample solutions and standard solutions required for the analysis.  Resulted chromatograms 
were shown in the figure-22&23 and data was shown in the  table  no.12, 13, 14, 15.
Figure-22 Chromatograms for Ruggedness
Figure-23 Chromatograms for Intermediate Precision
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Table No: 12  Data for ruggedness and intermediate precision   (4-Aminophenol)
No of Injection RT Theoretical
plate 
Tailing factor Peak response
01 4.71 9550 1.0 671190
02 4.71 9544 1.0 669650
03 4.71 9569 1.0 669055
04 4.71 9561 1.0 665927
05 4.71 9524 1.0 665060
06 4.72 9508 1.0 662250
Mean 4.71 9543 1.0 667189
SD 0.0 23 0.0 3349
%RSD 0.0 0.2 0.2 0.5
Table No: 13  Data for ruggedness and intermediate precision(Acetaminophen)
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No of Injection RT Theoretical
plate 
Tailing factor Peak response
01 9.27 15655 1.1 1636222
02 9.27 15675 1.1 1635268
03 9.27 15662 1.1 1636067
04 9.29 15643 1.1 1634471
05 9.29 15589 1.1 1634828
06 9.31 15602 1.1 1636635
Mean 9.28 15638 1.1 1635582
SD 0.01 35 0.0 855
%RSD 0.2 0.2 0.1 0.1
Table No: 14 Data for ruggedness and intermediate  precision  (4- chloroacetanilide) 
                                                                                              
No of Injection RT Theoretical
plate 
Tailing factor Peak response
01 37.46 219780 1.0 30864
02 37.46 224300 1.0 30123
03 37.47 223459 1.0 30026
04 37.47 223522 1.0 29997
05 37.48 223599 1.0 29880
06 37.48 223977 1.0 29749
Mean 37.47 223106 1.0 30106
SD 0.01 1660 0.0 393
%RSD 0.0 0.7 0.4 1.3
Table No: 15 Results of  ruggedness and intermediate precision
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System Suitability
Parameters
Results
Acceptanc
e criteria
4-
aminopheno
l
Acetaminophe
n
4-
Chloroacetanili
de
Tailing factor for 
Acetaminophen, 4-
Aminophenol and 4-
Chloroacetanilide 
peaks from first 
standard injection.
1.0 1.1 1.1 NMT 2.0
Theoretical plate 
count for 
Acetaminophen, 4-
Aminophenol and 4-
Chloroacetanilide 
peaks from first 
standard injection.
9550 15655 219780 NLT 2000
 The %RSD of RT for 
six replicate injection 
of standard solution 
(for 4-Aminophenol, 
Acetaminophen and 
4-Chloroacetanilide)
0.0 0.2 0.0 NMT 1.0
 The %RSD of Peak 
response from six 
replicate injection of 
standard solution (for 
4-Aminophenol, 
Acetaminophen and 
4-Chloroacetanilide)
0.5 0.1 1.3 NMT 2.0
 Resolution between 4-
Aminophenol and 
Acetaminophen 
injection from first 
standard injection.
18.7 7.4 NLT 2.0
 Confidence limits 3.52 N/A 2.04
± 5.0%
% recovery of known 
impurities in six 
spiked samples
104.3 N/A 99.1 90.0-110.0
 % RSD of known 
impurities in six 
spiked samples.
4.2 N/A 2.6 NMT 10.0
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 60
Method Validation for Related Substances
 % RSD of known 
impurities in 12 
replicate samples by 
Analyst-1 & Analyst-
2
3.4 N/A 2.0
LIMIT OF DETECTION AND LIMIT OF QUANTITATION:
Limit of Detection (LOD)
The limit of detection was determined by the analysis of samples with known concentrations 
of analyte and by establishing the minimum level at which the analyte could be reliably 
detected with a signal to noise ratio of about 3:1. Resulted chromatogram was shown figure-
24 and data was shown in the table no: 16.
LOD Solution:
                        Figure-24 Chromatogram for LOD
 
                                  Table No: 16 Data for LOD
Name Concentration inppm
%  RSD Signal to noise ratio
4-aminophenol 0.04 2.5 3.8
4-Chloroacetanilide 0.01 2.5 4.1
Acetaminophen 0.02 1.0 3.3
Limit of Quantitation (LOQ):
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The limit of quantitation  was  demonstrated by the analysis of samples with known 
concentrations of  analyte and  by establishing the minimum level at which the  analyte  could
be determined  with acceptable  accuracy and precision  with a signal to noise ratio of 10:1. 
Resulted chromatogram was shown figure-25 and data was shown in the table no 17.
LOQ Solution:          
                  Figure-25  Chromatogram for LOQ
                                  Table No: 17  Data for LOQ
Name Concentrationin ppm
%  RSD Signal to noise
ratio
4-aminophenol 0.12 1.0 11.1
4-Chloroacetanilide 0.03 0.6 10.4
Acetaminophen 0.06 2.1 11.0
Acceptance criteria:
1) The signal to noise ratio should be 3:1 for LOD and 10:1 for LOQ.
2) The % Relative standard deviation for six replicate LOQ level areas should be NMT 10%.
LINEARITY AND RANGE
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Linearity &Range
Standard solutions of Acetaminophen, 4-Aminophenol and 4-Chloroacetanilide in the 
concentration levels from 50 % to 150 % of standard solution were injected into HPLC 
system. The linearity graph was plotted from 50 % to 150% of drug concentration. Resulted 
chromatograms were shown figures-26,27,28,29,30,31,32,33 and data was shown in the 
tables no18,19,20,21,22,23.
Acceptance criteria
a. The correlation coefficient (r) must be NLT 0.999.
b. The RSD of replicate injections for lower and upper level concentrations should not 
be more than 2.0 %. 
Figure -26 Chromatograms for linearity-50%
Figure -27 Chromatograms for linearity-75%
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              Figure-28 Chromatograms for linearity-100%
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Figure -29 Chromatograms for linearity-125%
             Figure -30 Chromatograms for linearity-150%
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Figure- 31 Linearity curve for Acetaminophen
0 20 40 60 80 100 120 140 160
0
500000
1000000
1500000
2000000
2500000
3000000
Acetaminophen Linearity
                    Table No: 18  Data for linearity (Acetaminophen)
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Sample Weight in
mg
Peak Area Conc. in  %
Sample 2
50.76
5317 LOQ
Sample 3 954889 50
1369691 75
Sample 4 1836781 100
Sample 5 2323373 125
Sample 6 2825739 150
                  Table No: 19 Results of   linearity (Acetaminophen)
Acceptance criteria:  
System Suitability Parameters Results Acceptance
criteria
Correlation coeff. (r) 0.999 NLT 0.999
The % RSD of six replicate injection
Lower
Middle
Higher
2.1
0.2
0.0
NMT 2.0
% of y-Intercept -0.1
±2.0
Figure-32   Linearity curve for   4-Aminophenol
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0.00
200000.00
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4-Aminophenol Impurity Linearity
Table No: 20   Data for linearity (4-Aminophenol)
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Sample Weight in mg Peak Area Conc. in  %
Sample 1
50.18
4329 LOQ
Sample 2 314922 50
Sample 3 506104 75
Sample 4 689002 100
Sample 5 816023 125
Sample 6 984526 150
                 Table No: 21 Results of   linearity (4-Aminophenol)
  
System Suitability Parameters Results Acceptance
criteria
Correlation coeff. (r) 0.999 NLT 0.999
The % RSD of six replicate injection
Lower
Middle
Higher
1.0
0.7
0.7 NMT 2.0
% of y-Intercept 0.5
±2.0
Figure- 33   Linearity  curve for  4-Chloroacetanilide
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4-Chloroacetanilide Impurity Linearity
Table No: 22 Data for linearity (4-Chloroacetanilide)
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Sample Weight in mg Peak Area Conc. In  %
Sample 1
20.34
3939 LOQ
Sample 2 13219 50
Sample 3 20265 75
Sample 4 26434 100
Sample 5 33390 125
Sample 6 40517 150
Table No: 23 Results of linearity (4-Chloroacetanilide)
System Suitability Parameters Results Acceptance
criteria
Correlation coeff. (r) 0.999 NLT 0.999
The % RSD of six replicate injection
Lower
Middle
Higher
0.6
1.9
1.7 NMT 2.0
% of y-Intercept -1.2
±2.0
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ACCURACY 
Study of this analytical method was carried out by were drug concentration in  the range of 
50%-150%.resulted chromatograms were shown in the figures-34,35,36,37 and data was 
shown in the table no.24,25,26.
Figure -34  Chromatogram for sample of LOQ concentration
Figure-35 Chromatogram  for sample of 50% concentration
Figure-36 Chromatogram  for sample of 100% concentration
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Figure-37 Chromatogram  for sample of 150% concentration
      Table no: 24 Data for accuracy (4-aminophenol)
S. No
Accuracy
Level 
Sample
Added in
mg
Recovery 
in %
Average
Recovery in %
RSD in
%
01
LOQ Sol 8046.53 103.6
103.1 0.4LOQ Sol 8034.96 102.6
LOQ Sol 8017.15
103.0
02
50.0% 8021.71 103.9
103.5 0.350.0% 8030.25 103.1
50.0% 8027.96 103.6
03
100.0% 8028.12 101.4
101.4 0.4100.0% 8052.44 100.9
100.0%
8040.55 102.0
04
150.0% 8031.30 100.8
100.9 0.3150.0% 8013.89 101.2
150.0%
8020.06 100.6
Average 102.2
SD 1.3
% RSD 1.3
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Table no.25 Data for  accuracy (4-Chloroacetanilide)
S. No
Accuracy
Level 
Sample
Added in
mg
Recovery 
in %
Average
Recovery in %
RSD in
%
01
LOQ Sol 8046.53 102.9
105.5 1.8LOQ Sol 8034.96 106.2
LOQ Sol 8017.15
107.3
02
50.0% 8021.71 98.7
100.4 1.350.0% 8030.25 100.4
50.0% 8027.96 102.0
03
100.0% 8028.12 98.1
99.0 0.7100.0% 8052.44 99.8
100.0%
8040.55 99.2
04
150.0% 8031.30 97.4
98.8 1.5150.0% 8013.89 98.1
150.0%
8020.06 100.9
Average 100.9
SD 3.13
% RSD 3.1
Table no.26 Results data for accuracy
System Suitability
Parameters
Results
Acceptanc
e criteria
4-
Aminophen
ol
Acetaminoph
en
4-
Chloroacetanili
de
Tailing factor for 
Acetaminophen, 4- 1.0 1.0 1.0
NMT 2.0
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 72
Method Validation for Related Substances
Aminophenol and 4-
Chloroacetanilide peaks from 
first standard injection.
Theoretical plate count for 
Acetaminophen, 4-
Aminophenol and 4-
Chloroacetanilide peaks from 
first standard injection.
11374 16164 202495 NLT 2000
 The %RSD of RT for six 
replicate injection of standard
solution (for 4-Aminophenol, 
Acetaminophen and 4-
Chloroacetanilide) 
0.5 0.1 0.0 NMT 1.0
 The %RSD of Peak response 
from six replicate injection of
standard solution (for 4-
Aminophenol, 
Acetaminophen and 4-
Chloroacetanilide)
0.8 0.4 0.8 NMT 2.0
Resolution between 4-
Aminophenol and 
Acetaminophen injection 
from first standard injection.
18.9 9.0 NLT 2.0
The % Recovery at LOQ 
level
103.1 N/A 105.5
80.0 -
120.0
The% Recovery at 50% to 
150% level
103.5
101.4
100.9
N/A
100.4
99.0
98.8
90.0-110.0
% RSD of recovery 1.2 N/A 3.1 NMT10.0
ROBUSTNESS
Robustness was performed for this analytical method by chromatograms selected Parameters 
as given below and resulted chromatograms were shown in the figures-38 to 49  and data was
shown in the table no:27to29.
Department of Pharmaceutical analysis, K.M college of pharmacy, Madurai. Page 73
Method Validation for Related Substances
Method Parameters: 
1. Flow Rate
    (Normal  flow is 1.0 mL/min)
a. Reduced flow  
®
 0.8 mL/min
b. Increased flow 
®
1.2 mL/min
2. Column Operating Temperature
    (Normal temperature is 30 °C)
a. Reduced Temperature  
®
  28 °C
b. Elevated Temperature  
®
  32 °C
3. wavelength
    (Normal wavelength is 245nm)
a. Reduced wavelength  
®
  243nm
b. Elevated wavelength  
®
  247nm
Acceptance Criteria
   All the system suitability requirements must be met.
Figure- 38 chromatogram for standard with reduced Flow rate
Figure -39 Chromatogram for Spiked sample with reduced Flow rate
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Figure-40 Chromatogram for standard with increased Flow rate
Figure -41 Chromatogram for sample with increased  Flow rate 
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Table no. 27 Results  for Flow rate parameter
System Suitability
Parameters
Results
Acceptance
criteria4-
aminophenol
Acetaminophe
n
4-
Chloroacetanilid
e
Tailing factor for 
Acetaminophen, 4-
Aminophenol and 
4-
Chloroacetanilide 
peaks from first 
standard injection.
1. 0.8 ml/min 
2. 1.0 ml/min 
3. 1.2 ml/min 
1.0
1.1
0.9
1.0
1.0
0.9
1.0
1.0
0.9
NMT 2.0
Theoretical plate 
count for 
Acetaminophen, 4-
Aminophenol and 
4-
Chloroacetanilide 
peaks from first 
standard injection.
1. 0.8 ml/min 
2. 1.0 ml/min 
3. 1.2 ml/min
8869
6865
8165
17178
10374
13896
170545
145149
212469
NLT 2000
 The %RSD of RT 
for six replicate 
injection of 
standard solution 
(for 4-
Aminophenol, 
Acetaminophen 
and 4-
Chloroacetanilide)
1. 0.8 ml/min 
2. 1.0 ml/min 
3. 1.2 ml/min
0.0
0.2
0.1
0.2
0.3
0.1
0.0
0.1
0.0
NMT 1.0
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 The %RSD of Peak 
response from six 
replicate injection 
of standard solution
(for 4-
Aminophenol, 
Acetaminophen 
and 4-
Chloroacetanilide)
1. 0.8 ml/min 
2. 1.0 ml/min 
3. 1.2 ml/min
0.8
0.8
0.4
1.3
0.2
0.6
1.7
0.7
0.8
NMT 2.0
 Resolution between
4-Aminophenol 
and Acetaminophen
injection from first 
standard injection.
0.8 ml/min 
1.0 ml/min 
1.2 ml/min
18.8
14.7
16.5
N/A N/A NLT 2.0
 % recovery of 
known impurities
0.8 ml/min 
1.0 ml/min 
1.2 ml/min
98.1
102.5
104.4
N/A 99.6
101.2
102.8
90.0-110.0
The  %  RSD
between the results
of  known
impurities  obtained
with three different
flow rates.
3.2 N/A 0.9 NMT 10.0
Figure -42 Chromatogram for standard with  reduced Temperature
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Figure -43 Chromatogram for sample with reduced  Temperature
Figure-44 Chromatogram  for standard with increased Temperature
Figure -45 Chromatogram for  sample with increased Temperature
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Table no.28 Results  for Temperature parameter
System Suitability
Parameters
Results
Acceptance
criteria
4-
aminophen
ol
Acetaminophe
n
4-
Chloroacetanilid
e
Tailing factor for 
Acetaminophen, 4-
Aminophenol and 
4-
Chloroacetanilide 
peaks from first 
standard injection.
1. 28°C
2. 30°C
3.  32°C
1.1
1.1
1.4
1.0
1.0
1.1
1.1
1.0
1.1
NMT 2.0
Theoretical plate 
count for 
Acetaminophen, 4-
Aminophenol and 
4-
Chloroacetanilide 
peaks from first 
standard injection.
1. 28°C
2. 30°C
3. 32°C
6995
6865
4976
9711
10374
7011
125989
145149
97468
NLT 2000
 The %RSD of RT 
for six replicate 
injection of 
standard solution 
(for 4-
Aminophenol, 
Acetaminophen and
4-
0.1
0.2
0.0
0.1
0.3
0.0
0.0
0.1
0.0
NMT 1.0
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Chloroacetanilide)
1. 28°C
2. 30°C
3. 32°C
 The %RSD of Peak 
response from six 
replicate injection 
of standard solution
(for 4-
Aminophenol, 
Acetaminophen and
4-
Chloroacetanilide)
1. 28°C
2. 30°C
3. 32°C
0.5
0.8
0.2
1.7
0.2
0.7
0.9
0.7
0.9
NMT 2.0
 Resolution between 
4-Aminophenol and
Acetaminophen 
injection from first 
standard injection.
1. 28°C
2. 30°C
3. 32°C
14.8
14.7
11.9
N/A N/A NLT 2.0
 % recovery of 
known impurities
1. 28°C
2. 30°C
3. 32°C
99.2
102.5
99.0
N/A 100.1
101.2
102.4
90.0-110.0
The  %  RSD
between  the  results
of  known
impurities  obtained
with three  different
temperatures.
2.0 N/A 1.1
NMT 10.0
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Figure -46 Chromatogram for standard with reduced wavelength
Figure -47 chromatogram for sample with reduced wavelength
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Figure-48 Chromatogram for standard with  increased wavelength
Figure-49 chromatogram for sample with increased wavelength
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Table -29  Results  for wavelength parameter
System
Suitability
Parameters
Results
Acceptanc
e criteria4-
aminopheno
l
Acetaminophe
n
4-
Chloroacetanilide
Tailing factor for 
Acetaminophen, 
4-Aminophenol 
and 4-
Chloroacetanilide 
peaks from first 
standard injection.
1. 243nm 
2. 245nm
3. 247nm 
1.0
1.0
1.2
1.1
1.1
1.1
1.1
1.1
1.1
NMT 2.0
Theoretical plate 
count for 
Acetaminophen, 
4-Aminophenol 
and 4-
Chloroacetanilide 
peaks from first 
standard injection.
1. 243nm 
2. 245nm
8554
9550
8482
14595
15655
14593
211765
219780
213126
NLT 2000
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3. 247nm
 The %RSD of RT 
for six replicate 
injection of 
standard solution 
(for 4-
Aminophenol, 
Acetaminophen 
and 4-
Chloroacetanilide)
1. 243nm 
2. 245nm
3. 247nm
0.0
0.0
0.0
0.1
0.2
0.1
0.0
0.0
0.0
NMT 1.0
 The %RSD of Peak
response from six 
replicate injection 
of standard 
solution (for 4-
Aminophenol, 
Acetaminophen 
and 4-
Chloroacetanilide)
1. 243nm 
2. 245nm
3. 247nm
0.5
0.5
0.5
0.1
0.1
0.1
0.6
1.3
1.1
NMT 2.0
 Resolution 
between 4-
Aminophenol and 
Acetaminophen 
injection from first
standard injection.
1. 243nm 
2. 245nm
3. 247nm
17.7
18.7
17.7
N/A N/A NLT 2.0
 % recovery of 
known impurities
1. 243nm 101.2
N/A
103.1
90.0-110.0
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2. 245nm
3. 247nm
100.7
99.1
96.7
100.2
The  %  RSD
between the results
of  known
impurities obtained
with three different
Wavelengths.
1.1 N/A 3.5 NMT 10.0
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8. RESULTS AND DISCUSSION
The  method  was  developed  with  gradient  program  of   mobile  phase  A was
1-pentane sulphonic acid sodium salt buffer pH 6.0 (Buffer-1) and methanol (85:15) v/v and
mobile  phase  B was  potassium dihydrogen  orthophosphate  buffer  pH 3.0  (Buffer-2)  and
acetonitrile in the ratio (70:30) v/v with flow rate 1.0 ml/min on  Zodiac C-18, (250 × 4.6
mm, 5 µ) with UV detection at 245 nm gave a satisfactory chromatogram with run time
55 min.
          The present  proposed system provides  shorter  analysis  time and
conserves  mobile  phase  system.  The  method  was  validated  based  on  United  States
pharmacopoeia  and ICH parameters.  The parameters  are  accuracy,  precision,  LOD,  LOQ
linearity,  range specificity, ruggedness and robustness.
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Results of validation parameters for 4-Aminophenol:
s.n
o
Parameter Experiment Result Specification
1. System 
suitability %RSD 0.4
The % RSD of standard area should
be NMT 2.0
2
Specificity Placebo interference Nill
0.4
The Placebo should not show any 
peak at the retention time of 4-
Aminophenol, Acetaminophen and 
4-Chloroacetanilide peaks.
3. Precision System Precision 0.4 The % RSD of standard should be NMT 2.0
Method Precision
0.8
0.42
The % RSD of Impurity value 
obtained in spiked samples should 
not be more than 10.0.
The Confidence limits should be ± 
5.0%
Intermediate          Precision
4.2
3.52
The % RSD of Impurity value 
obtained in spiked samples not 
more than 10.0.
The Confidence limits should be ± 
5.0%.
4. Ruggedness
System to System
Variability 2.1
The % RSD of Impurity value 
obtained in spiked samples should 
not be more than 10.0.
Column to Column
Variability 2.1
The % RSD of Impurity value 
obtained in spiked samples should 
not be more than 10.0.
Analyst to Analyst qualification 2.1 The % RSD of Impurity value 
obtained in spiked samples should 
not be more than 10.0.
5. Lod Detection of limit 2.5 The %RSD should not more than 20.0
6. Loq Quantification of limit 1.0 The % RSD should not more than 10.0
7. Linearity and Range Coefficient of correlation   ( r)
0.999
0.5
The correlation co-efficient (r) 
should not be less than 0.999.
% of y-Intercept should be ±2.0
8. Accuracy Recovery
103.1
102.2
1.3
The % Recovery at LOQ level 
80.0% - 120.0%.The % Recovery at
50% to 150% level 90.0% - 
110.0%. RSD should not be more 
than 10.0%.
9. Robustness Effect of variation temperature 2.0
The % RSD of Impurity value 
obtained in spiked samples should 
not be more than 10.0.
Effect of variation in flow rate 3.2
The % RSD of Impurity value 
obtained in spiked samples should 
not be more than 10.0.
Effect of variation in
wavelength 1.1
The % RSD of Impurity value
Obtained in spiked samples should
not be more than 10.0 .
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Results of validation parameters for  4-Chloroacetanilide:
s.n
o
Parameter Experiment Result
s
Specification 
1. System 
suitability
   %RSD 0.9 The % RSD of standard area should be 
NMT 2.0
2 Specificity Placebo 
interference
 
Nill
0.4
The Placebo should not show any peak at 
the retention time of 4-Aminophenol, 
Acetaminophen and 4-Chloroacetanilide 
peaks.
3. Precision System Precision
0.9 The % RSD of standard should be NMT 
2.0
Method Precision 2.1
0.56
The % RSD of Impurity value obtained in 
spiked samples should not be more than 
10.0.
The Confidence limits should be ± 5.0%
Intermediate        
Precision 
2.6
2.04
The % RSD of Impurity value obtained in 
spiked samples not more than 10.0.
The Confidence limits should be ± 5.0%.
4. Ruggedness
System to 
System 
Variability
2.6
The % RSD of Impurity value obtained in 
spiked samples should not be more than 
10.0.
Column to 
Column
 Variability
2.6
The % RSD of Impurity value obtained in 
spiked samples should not be more than 
10.0.
Analyst to 
Analyst 
qualification
2.6
The % RSD of Impurity value obtained in 
spiked samples should not be more than 
10.0.
5. Lod Detection of 
limit
2.5
The %RSD should not more than 20.0 
6. Loq 
Quantification of
limit 0.6
The % RSD should not more than 10.0
7. Linearity 
and Range
Coefficient of 
correlation   ( r)
0.999
-1.2
The correlation co-efficient (r) should not 
be less than 0.999.
% of y-Intercept should be ±2.0
8. Accuracy Recovery 105.5
100.9
3.1
The % Recovery at LOQ level 80.0% - 
120.0%.
The % Recovery at 50% to 150% level 
90.0% - 110.0%. 
RSD should not be more than 10.0%.
Effect of The % RSD of Impurity value obtained in 
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9. Robustness 
 
variation 
temperature
2.0 spiked samples should not be more than 
10.0.
Effect of 
variation in flow 
rate
0.9
The % RSD of Impurity value obtained in 
spiked samples should not be more than 
10.0.
Effect of 
variation in 
wavelength
1.1
The % RSD of Impurity value 
Obtained in spiked samples should 
not be more than 10.0 .
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                                                                                                                               Conclusion
                                                           9.  CONCLUSION
As per the aim of present work, the RP-HPLC method was developed to estimate the related
substances of acetaminophen in acetaminophen,  phenylephrine Hcl and dextromethorphan
HBr  in  soft  gelatin  capsules.  From  the  result  of  validation  parameters  obtained,  it  was
observed  that  the  developed  method was  proven  to  be  specific,  precise,  linear,  accurate,
rugged and robust and is suitable for its intended purpose.
Hence it was concluded that this method  could be used for the routine estimation of related
substances of acetaminophen in acetaminophen, phenylephrine Hcl, dextromethorphan HBr
in soft gelatin capsules.
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